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Abstract The JunB gene is activated by many stimuli including
transforming growth factor L (TGFL) family members and
interleukin-6 (IL-6). Here the effect of TGFL activated kinase 1
(TAK1), a mitogen activated protein kinase kinase kinase
(MAPKKK) implicated in TGFL, bone morphogenetic protein
(BMP) and interleukin-1 (IL-1) signaling, on JunB promoter
activity was investigated. Promoter analysis led to the identifica-
tion of a CCAAT motif in the JunB gene, essential for activation
by TAK1. Transfer of this CCAAT element to a heterologous
minimal promoter conferred TAK1-responsiveness. The
CCAAT-binding transcription factor, nuclear factor Y (NF-Y),
activated the JunB promoter and a dominant negative NF-YA
construct inhibited TAK1 activation of JunB. Our results
demonstrate that JunB gene activation by TAK1 is mediated
by the CCAAT-binding factor NF-Y. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The mitogen activated protein kinase (MAPK) signaling
cascades are involved in multiple biological processes and
are activated by various stimuli including growth factors,
stress-inducing agents and 12-O-tetradecanoylphorbol-13-ace-
tate (TPA) [1^3]. The MAPK kinase kinase (MAPKKK)
transforming growth factor L (TGFL) activated kinase 1
(TAK1) has been identi¢ed as a mediator of TGFL, bone
morphogenetic protein (BMP) and interleukin-1 (IL-1) signal-
ing [4^6]. TAK1 binding protein 1 and 2 (TAB1 and TAB2)
are adapter proteins that activated TAK1 in response to
TGFL and IL-1, respectively [7,8].
The JunB gene, a member of the AP-1 family of transcrip-
tion factors, is induced by TGFL, IL-6, activators of protein
kinase A (PKA) and TPA [9^12]. Previously, we showed that
a Smad-binding element can mediate activation of the JunB
gene by TGFL [13]. In this manuscript we have analyzed JunB
activation by IL-1, TGFL and TAK1. The aim of this study
was to identify the JunB promoter region responsive to TAK1
and the factor that mediates this activation. We found that
JunB promoter activation by TAK1 requires a CCAAT motif
and depends on the CCAAT-binding transcription factor, nu-
clear factor Y (NF-Y).
2. Materials and methods
2.1. Plasmids
The JunB promoter constructs used are described in [13]. The 3U
CCAAT Luc, 2UIR Luc and the 2UGC Luc reporters were gener-
ated by insertion of concatamerized synthetic oligonucleotides in the
BglII site of pGL3ti (see [13] for pGl3ti). The vCCAAT Luc construct
was constructed using polymerase chain reaction (PCR). NF-YA and
NF-YA29 expression plasmids and KNF-YB antibodies were gener-
ous gifts of Dr. R. Mantovani; TAK1, TAB1 and K63W plasmids
were generously provided by Dr. K. Matsumoto.
2.2. Reverse transcription (RT)-PCR
Total RNA was isolated from HepG2 cells, using Trizol, according
to the supplied protocol (Life Technologies). RNA was reverse tran-
scribed with M-MuLV (Boehringer Mannheim) and subjected to
PCR. After 35 cycles, 10 Wl of the reaction volume was resolved on
agarose gels and photographed. The sequences of the PCR primers
used were: JunB: forward: CCAGTCCTTCCACCTCGACGTTTA-
CAAG, reverse: GACTAAGTGCGTGTTTCTTTTCCACAGTAC;
GAPDH: forward: ATCACCATCTTCCAGGAG, reverse: GCCA-
TCCACAGTCTTC.
2.3. Cell culture and transient transfection
HepG2 and NIH-3T3 cells were maintained in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum
(HepG2) or 10% NCS (NIH-3T3), 100 IU/ml penicillin, 1 mg/ml
streptomycin, 2 mM L-glutamine and 1UMEM non-essential amino
acids (Life Technologies). For transient transfections, 100 000 NIH-
3T3 cells were seeded per 35-mm dish and transfected using the cal-
cium phosphate co-precipitation method. The following day, the me-
dia was changed and 48 h after transfection the cells were harvested in
reporter lysis bu¡er (Promega). Luciferase activity was determined
using the Promega luciferase assay system. In all transfections, a
L-galactosidase expression plasmid (pDM2LacZ, [14]) was included
to normalize luciferase activities. L-Galactosidase activity was deter-
mined in 100 mM Na2HPO4/NaH2PO4, 1 mM MgCl2, 100 mM
2-mercaptoethanol and 0.67 mg/ml O-nitrophenylgalactopyranoside.
All transfections were carried out in triplicate and repeated at least
twice in independent experiments using di¡erent batches of plasmid
DNA.
2.4. Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from NIH-3T3 cells as described in
[15]. Annealed oligonucleotides (forward: GATCCCGCGTCGGC-
CAATCGGAGTGCACA; reverse: GATCTGTGCACTCCGATTG-
GCCGACGCGG) were labeled using T4 polynucleotide kinase and
[Q-32P]ATP and puri¢ed with spin columns (Qiagen). Binding reac-
tions were carried out for 30 min at room temperature in 10 mM
Tris pH 8.0, 1 mM EDTA pH 8.0, 2 mM MgCl2, 5% glycerol,
1 mM dithiothreitol, 1 mM phenylmethylsulfonyl £uoride and
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0.01% NP-40 containing 5 Wg extract, 1 Wg poly(dI-dC), 50 000 cpm
probe and where appropriate 5-, 10- or 100-fold molar excess com-
petitor oligos. Preincubation with NF-YB antibodies (240 ng/sample)
was carried out at room temperature, 30 min prior to probe addition.
Before loading onto 5% polyacrylamide gels (0.5UTBE), 20% Ficoll
was added to the reactions, after electrophoresis gels were dried and
autoradiographed.
3. Results
3.1. IL-1 and TGFL activate the JunB gene
To determine the e¡ect of IL-1 and TGFL on JunB gene
expression, HepG2 cells were stimulated with IL-1 or TGFL
for 1 h and JunB mRNA levels were determined using RT-
PCR analysis. Both TGFL, as was shown earlier [9], and IL-1
induced JunB gene expression (Fig. 1, panel JunB) whereas
GAPDH expression levels were not altered (Fig. 1, panel
GAPDH). To control for the presence of genomic DNA, total
RNA from all experimental conditions was pooled and sub-
jected to PCR. No signi¢cant ampli¢cation of either JunB or
GAPDH was observed (Fig. 1, lane 3RT).
3.2. TAK1/TAB1 transactivates the proximal JunB promoter
Since TAK1 has been implicated in both TGFL and IL-1
signaling [4,6], we next determined the e¡ect of TAK1 on the
JunB promoter. A minimal promoter fragment (387 Luc),
still responsive to TAK1, was identi¢ed by progressive dele-
tion of 5P-JunB promoter sequences. Although a decrease in
basal promoter activity was observed, the fold-activation by
TAK1 was largely una¡ected by removal of upstream sequen-
ces (Fig. 2A). A catalytically inactive TAK1 mutant, K63W,
did not result in reporter activation and promoter stimulation
by TAK1 was TAB1-dependent (Fig. 2B).
3.3. TAK1 activates the 387 Luc reporter via a CCAAT box
The smallest TAK1-responsive construct, 387 Luc, con-
tained 47 nucleotides (nt) of JunB sequence, including a
GC-rich sequence, an inverted repeat and a CCAAT box
(see Fig. 3). Reporters containing multiple copies of these
elements were generated and tested for TAK1-responsiveness.
Reporters either containing the inverted repeat or the GC-rich
motif were not activated by TAK1 (data not shown) whereas
a reporter containing three CCAAT boxes (3UCCAAT Luc)
was stimulated by TAK1 (4.2-fold induction, Fig. 3). Next, a
point mutation was introduced in the CCAAT sequence
(CCAATCCCGAT) which resulted in a complete loss of
TAK1-responsiveness. These results indicated that a CCAAT
motif can confer TAK1-sensitivity and that activation of the
proximal JunB promoter by TAK1 is dependent on the pres-
ence of an intact CCAAT motif (Fig. 3).
Fig. 1. Activation of JunB gene expression by TGFL and IL-1.
HepG2 cells were either untreated (lane -) or treated with either
TGFL or IL-1 (lanes TGFL and IL-1). After 1 h, RNA was ex-
tracted and JunB and GAPDH mRNA levels were determined using
RT-PCR. The lane 3RT indicates pooled RNAs from all experi-
mental conditions, processed without reverse transcriptase. GAPDH
is used as an internal control.
Fig. 2. A: Analysis of the mouse JunB promoter in NIH-3T3 cells. The ¢gure to the left indicates the 5P-end of the tested promoter constructs,
in nt, relative to the ATG. The normalized activity of the reporter constructs is given as the average of at least two triplicates with the stan-
dard error of the mean (nv6). The ‘fold induction’ column to the right of the ¢gure gives the ratio of promoter activity between unstimulated
and TAK1/TAB1 stimulated reporters. B: Activation of the 387 Luc reporter by TAK1 is TAB1-dependent. The 387 Luc reporter was trans-
fected into NIH-3T3 cells with the plasmids indicated to the left of the ¢gure. The normalized luciferase activity is given as the average of at
least two triplicates with the standard error of the mean (nv6).
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3.4. NF-Y mediates activation of the JunB promoter by TAK1
The CCAAT box present in the 387 Luc construct, includ-
ing £anking sequences, matched a consensus NF-Y site [16].
Moreover, Bowden et al. recently showed that NF-Y mediates
JunB promoter activation in response to okadaic acid [17].
NF-Y is a ubiquitous heterotrimeric transcription factor con-
sisting of three subunits, NF-YA, NF-YB and NF-YC, of
which NF-YA contains a DNA-binding domain and a sub-
unit interaction domain and all three subunits are required for
DNA interaction [18]. We determined whether NF-Y acti-
vated the JunB promoter and mediated activation by TAK1.
The 387 Luc reporter was activated by both TAK1/TAB1
(3.5-fold induction) and NF-YA (4.3-fold induction, Fig. 4).
Simultaneous transfection of NF-YA, TAK1 and TAB1 with
the 387 Luc reporter further increased promoter activity (a
6.6-fold induction). Where a dominant negative NF-YA, NF-
YA29 [19], by itself had no signi¢cant e¡ect on promoter
activity, TAK1-mediated transactivation of the 387 Luc re-
porter was signi¢cantly inhibited by NF-YA29 (Fig. 4, com-
pare TAK1/TAB1 with TAK1/TAB1/NF-YA29) indicating
that TAK1 activation of JunB is dependent on NF-Y. As
expected, a catalytically inactive TAK1 construct (K63W)
had no e¡ect on promoter activation by NF-YA (Fig. 4).
3.5. NF-Y binds the JunB CCAAT sequence
To determine whether NF-Y binds the proximal JunB pro-
moter, EMSAs were performed using oligonucleotides con-
taining the JunB CCAAT element and £anking sequences.
To determine the speci¢city of the observed shifted complexes,
increasing amounts of unlabeled oligonucleotides were added
as competitor. Concentration-dependent competition for one
shifted complex was observed, indicating this complex specif-
ically bound to the probe (Fig. 5, arrow). Since Mantovani et
al. previously showed that KNF-YB polyclonal antibodies
prevented interaction between NF-Y and DNA [20], we
used these antibodies to determine whether the observed, spe-
ci¢c complex contained NF-Y. Preincubation with NF-YB
antibodies (lane 7) deprived NIH-3T3 nuclear extracts of the
Fig. 3. Identi¢cation of a CCAAT sequence in the JunB promoter as a response element required and su⁄cient for TAK1 activation. The
JunB promoter sequence present in the 387 Luc construct is depicted with the consensus NF-Y-binding sequence in capitals, the GC-rich box
is underlined and the inverted repeat is double underlined. The arrow points to the point mutation introduced in the vCCAAT Luc reporter.
The ‘fold induction’ column to the right of the ¢gure gives the ratio of promoter activity between unstimulated and TAK1/TAB1 stimulated re-
porters. The normalized luciferase activity is given as the average of at least two triplicates with the standard error of the mean (nv 6).
Fig. 4. NF-Y mediates TAK1 activation of the JunB promoter.
NIH-3T3 cells were transfected with the 387 Luc reporter and the
plasmids indicated to the left of the ¢gure. The normalized lucifer-
ase activity is given as the average of at least two triplicates with
the standard error of the mean (nv6).
Fig. 5. NF-Y binds the JunB CCAAT sequence. An end-labeled oli-
gonucleotide containing the JunB CCAAT sequence was incubated
with NIH-3T3 nuclear extracts. In lanes 3^5, respectively, 5-, 10-
and 100-fold molar excess unlabeled competitor oligonucleotide was
added. In lanes 6^7, nuclear extracts were preincubated with pre-im-
mune serum and NF-YB antibodies, respectively. The arrow indi-
cates the NF-Y containing complex.
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same DNA-binding activity that was competed for with excess
unlabeled oligos and preincubation with preimmune serum
(lane 6) had no e¡ect. These results indicated that the protein
complex speci¢cally binding to the JunB CCAAT sequence
element contained NF-Y.
4. Discussion
In this report we describe that activation of the JunB pro-
moter by the IL-1- and TGFL-activated MAPKKK TAK1 is
mediated through a CCAAT motif and NF-Y. Mutation anal-
ysis revealed that a CCAAT sequence element, localized 65 nt
5P of the ATG, was required for TAK1-mediated activation of
the JunB promoter. Through transfections and EMSAs we
demonstrated that NF-Y acted downstream of TAK1 and
showed NF-Y-binding to the JunB CCAAT motif.
4.1. TAK1 activation is mediated via a CCAAT box in
the proximal promoter
Analysis of a series of JunB promoter constructs indicated
the presence of a TAK1-responsive element in the 387 Luc
reporter. Activation of the JunB promoter constructs by
TAK1, depicted as ‘fold induction’, was not signi¢cantly al-
tered by deleting 5P-sequences. The observed decrease in basal
promoter activity is probably due to deletion of upstream
enhancer sequences. These results showed that the 387 Luc
JunB reporter construct contained a TAK1-responsive region
(Fig. 2A) but the presence of additional TAK1-responsive
sequence elements in upstream promoter sequences cannot
be excluded. Activation of the 387 Luc reporter by TAK1
is TAB1-dependent, suggesting TAK1 kinase activity is re-
quired for JunB activation (Fig. 1B) which is further illus-
trated by the observation that a catalytically inactive TAK1
mutant, K63W, failed to activate the 387 Luc reporter (Fig.
1B).
Sequence analysis of the 387 Luc reporter pointed to a
CCAAT box as a potential sequence element mediating
TAK1 activation of the JunB promoter. The JunB CCAAT
sequence element, including £anking sequences, completely
matched a consensus NF-Y-binding site de¢ned by Mantova-
ni [16]. Besides a preference for these £anking sequences, all
¢ve nucleotides of the CCAAT sequence are required for NF-
Y-binding which is in agreement with the observation that a
single point mutation in the JunB CCAAT sequence abolishes
responsiveness of the JunB promoter to TAK1 [16].
4.2. NF-Y mediates TAK1 activation of the JunB promoter
Transient transfections with the 387 Luc reporter showed
that NF-YA can activate this reporter (Fig. 3). Overexpres-
sion of the CCAAT-binding transcription factors C/EBP and
CTF/NF-I did not result in 387 Luc transactivation showing
that the JunB promoter is speci¢cally activated by NF-Y (Eg-
gen and Kruijer, unpublished results). Parallel overexpression
of either an inactive TAK1 mutant, K63W, or TAK1 had
little e¡ect on NF-YA induced activation of the JunB pro-
moter, indicating that when NF-YA is overexpressed, TAK1
kinase activity is not required for promoter transactivation
(Fig. 3).
To show that NF-Y mediates TAK1 activation of the JunB
promoter, transient cotransfections of TAK1 with a NF-
YA29 mutant were performed. The NF-YA29 construct car-
ries a mutation that destroys the DNA-binding ability of NF-
YA; the domain that is required for subunit interaction is not
changed [19]. Since all three subunits of NF-Y are required
for DNA binding, overexpression of NF-YA29 results in the
formation of NF-Y complexes that lack DNA-binding ability.
Since the CCAAT sequence was not occupied under these
conditions and overexpression of NF-YA29 strongly inhibited
activation of the JunB promoter by TAK1 we concluded that
NF-Y is the CCAAT-binding transcription factor that medi-
ated TAK1 activation of the JunB promoter.
In addition to these ¢ndings, EMSAs veri¢ed that NF-Y
binds the CCAAT sequence element in the JunB promoter.
Competition analysis indicated the presence of a speci¢c com-
plex and preincubation of nuclear extracts with KNF-YB anti-
bodies completely eliminated this complex.
At present it remains unclear how NF-Y activity is regu-
lated by TAK1. NF-Y consists of three subunits (NF-YA, -B
and -C) and each subunit is able to bind co-factors prior to
subunit association and DNA binding of the NF-Y complex.
TAK1 is a MAPKKK that has been shown to activate several
MAPKK^MAPK cascades. It is possible that phosphoryla-
tion of NF-Y subunits or NF-Y cofactors by (one of) these
TAK1-activated MAPK cascades modulates subunit^subunit
or subunit^cofactor interaction, complex stability or DNA-
binding properties of the complex, resulting in an increased
JunB transactivation. Further experiments however will be
required to delineate the exact mechanism of NF-Y activation
by TAK1.
In summary, our results indicate that TAK1, a MAPKKK
homolog positioned downstream of TGFL, BMPs and IL-1
activates the JunB gene through the CCAAT-binding tran-
scription factor NF-Y. The JunB gene is an immediate early
gene whose expression is rapidly upregulated in response to
multiple stimuli. Since the CCAAT motif is present in many
eukaryotic promoters and NF-Y is a common transcription
factor, it is an unlikely factor to mediate stimulus-speci¢c gene
activation. We hypothesize that the role of NF-Y in JunB
promoter activation is to enhance JunB promoter activation
by stimulus-speci¢c transcription factors like the Smad pro-
teins. Further experiments will have to determine whether and
how these pathways interact to modulate JunB promoter ac-
tivity in response to particular stimuli.
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